We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.48B
AUM Growth
+$119M
Cap. Flow
+$156M
Cap. Flow %
6.28%
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.89%
2 Financials 8.07%
3 Healthcare 5.89%
4 Consumer Discretionary 5.37%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUS icon
3276
Metallus
MTUS
$898M
$0 ﹤0.01%
18
-39
-68% -$534
QTTB icon
3277
Q32 Bio
QTTB
$464M
$0 ﹤0.01%
1
TRAW icon
3278
Traws Pharma
TRAW
$8.1M
$0 ﹤0.01%
+1
New +$129
RPT
3279
Rithm Property Trust
RPT
$93.7M
$0 ﹤0.01%
5
INVX
3280
Innovex International
INVX
$1.97B
-65
Closed -$2K
HTB
3281
HomeTrust Bancshares
HTB
$848M
-205
Closed -$6K
NAGE
3282
Niagen Bioscience
NAGE
$247M
-100
Closed -$1K
HYB
3283
DELISTED
New America High Income Fund, Inc.
HYB
$0 ﹤0.01%
1
SCWX
3284
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
-1
Closed
VIRX
3285
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$0 ﹤0.01%
8
GATO
3286
DELISTED
Gatos Silver, Inc.
GATO
-54
Closed -$1K
AKTS
3287
DELISTED
Akoustis Technologies Inc
AKTS
$0 ﹤0.01%
35
TCS
3288
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
-71
Closed -$14K
RCM
3289
DELISTED
R1 RCM Inc. Common Stock
RCM
-4
Closed
AXNX
3290
DELISTED
Axonics, Inc. Common Stock
AXNX
$0 ﹤0.01%
+4
New +$273
MKFG.WS
3291
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$0 ﹤0.01%
+250
New +$404
AMK
3292
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$0 ﹤0.01%
+8
New +$206
CONN
3293
DELISTED
Conn's Inc.
CONN
$0 ﹤0.01%
+19
New +$451
MCBC
3294
DELISTED
Macatawa Bank Corp
MCBC
$0 ﹤0.01%
31
+1
+3% +$8
EFTR
3295
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
-10
Closed -$2K
BIOL
3296
DELISTED
Biolase, Inc.
BIOL
0
THMO
3297
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
0
NURO
3298
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$0 ﹤0.01%
+1
New +$89
SP
3299
DELISTED
SP Plus Corporation
SP
-32
Closed -$1K
AFIB
3300
DELISTED
Acutus Medical Inc
AFIB
$0 ﹤0.01%
+12
New +$158

Similar funds

Parallel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $156M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.

  • Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
  • Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
  • Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
  • Parallel Advisors opened 363 new positions and closed 191 in Q3 2021.
  • Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.